title: Pharmacokinetic disposition and arthropathic potential of oral ofloxacin in dogs.
abstract: We examined the relation between the pharmacokinetic disposition and arthropathic potential of ofloxacin, a new quinolone antibacterial agent, using both male immature (3-month-old) and mature (18-month-old) beagles. Ofloxacin was orally administered to these dogs at 20 mg/kg once daily for 8 consecutive days, and the animals were killed 2 h after the last treatment. Serum ofloxacin concentrations were repeatedly measured on days 1 and 7 by use of high-performance liquid chromatography (HPLC), and pharmacokinetic parameters were calculated. In addition, on day 8, the drug concentrations in the joint synovial fluid and humeral and femoral condyles were measured. Clinico-pathological tests of blood and serum or histopathological examination of bone specimens were also performed. Arthropathy was macroscopically observed in the cartilage surface of all immature dogs, but not in mature dogs. There were, however, no noticeable differences in pharmacokinetic parameters between the two age groups of dogs or between single and 7-day treatments. In contrast to the occurrence of arthropathic lesions, the synovial fluid and condylar drug concentrations in immature dogs was equal to or lower than those in mature dogs, suggesting that the pharmacokinetic disposition of ofloxacin may not be essential for cartilage lesions.
authors.affiliation: Tokyo Research & Development Center, Daiichi Pharmaceutical Co. Ltd., Japan.
authors.forename: K
authors.initials: K
authors.lastname: Yoshida
authors.forename: K
authors.initials: K
authors.lastname: Yabe
authors.forename: S
authors.initials: S
authors.lastname: Nishida
authors.forename: N
authors.initials: N
authors.lastname: Yamamoto
authors.forename: C
authors.initials: C
authors.lastname: Ohshima
authors.forename: M
authors.initials: M
authors.lastname: Sekiguchi
authors.forename: K
authors.initials: K
authors.lastname: Yamada
authors.forename: K
authors.initials: K
authors.lastname: Furuhama
mesh_terms: D000284:Administration, Oral; D000367:Age Factors; D000818:Animals; D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000633:toxicity; D019540:Area Under Curve; D002358:Cartilage, Articular / Q000187:drug effects / Q000473:pathology; D004283:Dog Diseases / Q000097:blood / Q000139:chemically induced* / Q000503:physiopathology; D004285:Dogs; D007592:Joint Diseases / Q000662:veterinary*; D008297:Male; D015242:Ofloxacin / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000633:toxicity*; D013582:Synovial Fluid / Q000737:chemistry
chemical_list: D000890:Anti-Infective Agents; D015242:Ofloxacin